IDEXX Laboratories, Inc.
IDXX
Rang in Aktien
#556
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Aktienkurs
$559.82
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$44.10B
Veränderung (1 Tag)
2.31%
Veränderung (1 Jahr)
-11.89%
Land
US
Handel IDEXX Laboratories, Inc. (IDXX)
Kategorie
Healthcare
Operative Marge für IDEXX Laboratories, Inc. (IDXX)
Operative Marge zum October 2026 TTM: 32.03%
Laut den neuesten Finanzberichten und dem Aktienkurs von IDEXX Laboratories, Inc. beträgt die aktuelle operative Marge (TTM) 32.03%. Am Ende des Jahres 2024 lag die operative Marge bei 28.95%.
Historie der operativen Marge von IDEXX Laboratories, Inc. von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 32.03% | 1.36% |
| 2025 | 31.60% | 9.15% |
| 2024 | 28.95% | -3.40% |
| 2023 | 29.97% | 12.29% |
| 2022 | 26.69% | -7.93% |
| 2021 | 28.99% | 12.98% |
| 2020 | 25.66% | 11.71% |
| 2019 | 22.97% | 3.47% |
| 2018 | 22.20% | 5.82% |
| 2017 | 20.98% | 6.34% |
| 2016 | 19.73% | 5.40% |
| 2015 | 18.72% | 6.85% |
| 2014 | 17.52% | -9.55% |
| 2013 | 19.37% | -4.58% |
| 2012 | 20.30% | 4.75% |
| 2011 | 19.38% | 4.87% |
| 2010 | 18.48% | 8.32% |
| 2009 | 17.06% | 1.31% |
| 2008 | 16.84% | 14.09% |
| 2007 | 14.76% | -14.73% |
| 2006 | 17.31% | -4.21% |
| 2005 | 18.07% | -8.13% |
| 2004 | 19.67% | 16.46% |
| 2003 | 16.89% | 5.89% |
| 2002 | 15.95% | 8.87% |
| 2001 | 14.65% | 1.10% |
| 2000 | 14.49% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 17.97% | -99.44% |
US
|
|
| 20.42% | -99.36% |
US
|
|
| -10.70% | -100.33% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -99.31% |
US
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.